三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China boosts public health with vaccine and immunization progress

Xinhua | Updated: 2025-04-21 09:21
Share
Share - WeChat
This photo taken with a mobile phone shows a volunteer (R) helping Yemeni businessman Sufyan Marwan Sufyan Mohanmmed take vaccine reservation receipt for his daughter from a machine by scanning a QR code at a community health service center in Yiwu, East China's Zhejiang province, March 25, 2025. [Photo/Xinhua]

WUHAN -- China has made significant progress in vaccine development and immunization, marked by a growing portfolio of domestically produced vaccines and remarkable public health results.

These achievements were highlighted at the 2025 National Vaccines and Health Conference, held over the weekend in Wuhan, capital of Hubei Province in central China, and attended by nearly 3,000 public health officials and medical professionals.

Over the past years, China has achieved notable breakthroughs in vaccine technology. Milestones include the successful development of homegrown HPV and Ebola vaccines, as well as advances in pneumococcal conjugate vaccines against 13 types of bacteria and shingles vaccines.

Several Chinese vaccines have received prequalification from the World Health Organization, enabling their distribution in partner countries of the Belt and Road Initiative.

These advancements underscore a broader shift in China's vaccine industry -- from focusing primarily on domestic needs to increasingly contributing to the global vaccine supply chain, according to Wang Yunfu, head of the Health Commission of Hubei Province.

The global biotechnology landscape has also helped accelerate this transformation, as the participants pointed out. In recent years, breakthroughs in technologies such as mRNA platforms, viral vectors, and nanoparticle delivery systems have opened up unprecedented opportunities for vaccine research and development, significantly improving both efficiency and immune response.

Alongside scientific innovation, China has placed strong emphasis on safety and regulatory oversight. In 2019, it became the first country to implement a comprehensive vaccine administration law, followed by updated immunization standards introduced in 2023.

A nationwide traceability system has been set up, ensuring that every dose can be tracked from production to administration, enhancing transparency and public trust.

China's national immunization programs have yielded strong public health results.

The country achieved polio-free status in 2000, eliminated neonatal tetanus by 2012, and has reported no locally transmitted diphtheria cases since 2007. The prevalence of hepatitis B surface antigen among children under five declined from nearly 10 percent in 1992 to just 0.3 percent in 2020.

Routine vaccination coverage has remained above 90 percent nationwide, supported by an extensive healthcare infrastructure that ensures every township has at least one vaccination unit.

Efforts to expand access and improve service delivery remain a central priority. "Public health should be protected through more accessible and higher-quality vaccine services," said Li Bin, president of the Chinese Preventive Medicine Association, adding that this goal was reflected in the conference's theme.

For example, in Hubei, girls aged 14 are now eligible for free HPV vaccination, and immunization for newborns is being integrated into the birth registration process to ensure early and timely coverage.

Looking ahead, China is preparing to refine its immunization strategy and services further.

Health authorities are considering dynamic adjustments to the national immunization program to prioritize vaccines with high cost-effectiveness or those associated with costly diseases. In some regions, pilots may allow the use of personal health insurance accounts to cover non-mandatory vaccines, reducing out-of-pocket expenses for the public.

Digital tools will also play an increasing role in modernizing immunization services. Electronic vaccination records are being shared across provinces, while artificial intelligence (AI) is assisting with appointment scheduling. Big data platforms are improving vaccine inventory management and logistics.

Yin Zundong, head of the Immunization Program Center at the Chinese Center for Disease Control and Prevention, emphasized the role of advanced data technologies.

"With the help of big data and AI, disease surveillance and early warning systems can become more accurate and efficient," Yin said. "In the future, data-driven tools will enable precise assessments of vaccine protection efficacy."

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 在线97 | 欧美一区二区三区在线播放 | 精品一区二区三区高清免费观看 | 国产日韩中文字幕 | 日本成人网址 | 午夜在线亚洲男人午在线 | 91最新视频在线观看 | 亚洲综合在线最大成人 | 美国一级做a一级视频 | 精品久久电影 | 欧美一级日本一级韩国一级 | 国产伦精品一区二区三区 | 一区二区在线视频免费观看 | 91破解版在线 | 亚洲 | 手机看片久久国产免费不卡 | 黄色影院在线观看 | 国产亚洲精品自在线观看 | 成人性a激情免费视频 | 色天天天天综合男人的天堂 | 99热在线免费观看 | 丁香婷婷亚洲 | 欧美黄色录像 | 夜夜精品视频一区二区 | 可以免费观看的黄色网址 | 护士精品一区二区三区 | 色老99久久九九爱精品69堂 | 精品久久成人免费第三区 | 欧美一级视频 | 国产欧美成人一区二区三区 | 亚洲第一视频在线播放 | 亚洲成在人线av | 国产免费不卡v片在线观看 国产免费不卡视频 | 欧美一级片在线看 | 免费黄色片大全 | 成人毛片18岁女人毛片免费看 | 日韩做爰在线观看免费 | 精品一区二区91 | 欧美一级做a影片爱橙影院 欧美一级做一a做片性视频 | 黄色成人免费观看 | 成人在线视频免费看 | 国产精品成人观看视频免费 |